Journal
FUTURE MEDICINAL CHEMISTRY
Volume 9, Issue 2, Pages 245-265Publisher
FUTURE SCI LTD
DOI: 10.4155/fmc-2016-0207
Keywords
cancer; cysteine; cysteinome; disease; enzyme; inhibitor; kinase; kinome; pseudoenzyme; pseudokinase; signaling
Categories
Funding
- BBSRC [BB/N021703/1]
- BBSRC [BB/N021703/1] Funding Source: UKRI
- MRC [G120/1030] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/N021703/1] Funding Source: researchfish
- Medical Research Council [G120/1030] Funding Source: researchfish
Ask authors/readers for more resources
The pseudokinase complement of the human kinase superfamily consists of approximately 60 signaling proteins, which lacks one or more of the amino acids typically required to correctly align ATP and metal ions, and phosphorylate protein substrates. Recent studies in the pseudokinase field have begun to expose the biological relevance of pseudokinases, which are now thought to perform a diverse range of physiological roles and are connected to a multitude of human diseases, including cancer. In this review, we discuss how and why members of the `pseudokinome' represent important new targets for drug discovery, and describe how knowledge of protein structure and function provides informative clues to help guide the rational chemical design or repurposing of inhibitors to target pseudokinases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available